Literature DB >> 16759900

An integral care telemedicine system for HIV/AIDS patients.

Cesar Caceres1, Enrique J Gomez, Felipe Garcia, Jose M Gatell, Francisco del Pozo.   

Abstract

OBJECTIVE: In this article we will describe a new approach to improve the quality of care of chronic HIV/AIDS patients, combining the integral care approach with a telemedicine system.
METHODS: Following the integral care approach, we included the patient in a multidisciplinary care team, covering the whole process of care with a telemedicine system that allows the patient to improve his/her self-care and to be remotely followed-up by the healthcare professionals.
RESULTS: This challenge has been met by the creation of the "VIHrtual Hospital" project. Its main goal is the definition, development, clinical routine installation and evaluation of a telemedicine service that complements standard care with a telecare follow-up for treating stable HIV infected patients, in a chronic stage of their disease, and study if that improves the quality of assistance and the expense per patient compared to the conventional control (without telemedicine service) that patients usually have. Although the study is not yet finished, in the discussion the main benefits and drawbacks of this telemedicine system are described.
CONCLUSIONS: The main conclusion of the article is that a new home telecare model for chronic HIV/AIDS patients has been created and has been implemented through the "VIHrtual Hospital" in the Clinic Hospital in Barcelona (Spain). The architecture of this web-based system fulfills the demanding security and integration requirements of the IT department of the hospital. An easy-to-use graphical interface for both patients and professionals has also been developed. The low costs of the system allow us to cover a wide range of patients and promising results are being obtained regarding the use of telemedicine systems for improving the follow-up care of chronic HIV/AIDS patients and for creating a new care model for this disease.

Entities:  

Mesh:

Year:  2006        PMID: 16759900     DOI: 10.1016/j.ijmedinf.2006.04.010

Source DB:  PubMed          Journal:  Int J Med Inform        ISSN: 1386-5056            Impact factor:   4.046


  6 in total

1. 

Authors:  Walter H Curioso; Magaly M Blas; Ann E Kurth; Jeffrey D Klausner
Journal:  Rev Peru Med Exp Salud Publica       Date:  2007-07-27

2.  Healthcare provider attitudes, practices, and recommendations for enhancing routine HIV testing and linkage to care in the Mississippi Delta region.

Authors:  Nathan Sison; Annajane Yolken; Joanna Poceta; Leandro Mena; Philip A Chan; Arti Barnes; Erin Smith; Amy Nunn
Journal:  AIDS Patient Care STDS       Date:  2013-09       Impact factor: 5.078

3.  An evolutionary examination of telemedicine: a health and computer-mediated communication perspective.

Authors:  Gerald-Mark Breen; Jonathan Matusitz
Journal:  Soc Work Public Health       Date:  2010-01

4.  A new multidisciplinary home care telemedicine system to monitor stable chronic human immunodeficiency virus-infected patients: a randomized study.

Authors:  Agathe León; César Cáceres; Emma Fernández; Paloma Chausa; Maite Martin; Carles Codina; Araceli Rousaud; Jordi Blanch; Josep Mallolas; Esteban Martinez; Jose L Blanco; Montserrat Laguno; Maria Larrousse; Ana Milinkovic; Laura Zamora; Neus Canal; Josep M Miró; Josep M Gatell; Enrique J Gómez; Felipe García
Journal:  PLoS One       Date:  2011-01-21       Impact factor: 3.240

Review 5.  Telehealth: Increasing Access to High Quality Care by Expanding the Role of Technology in Correctional Medicine.

Authors:  Jeremy D Young; Melissa E Badowski
Journal:  J Clin Med       Date:  2017-02-13       Impact factor: 4.241

6.  EmERGE mHealth Platform: Implementation and Technical Evaluation of a Digital Supported Pathway of Care for Medically Stable HIV.

Authors:  Francisco J Gárate; Paloma Chausa; Jennifer Whetham; Christopher Iain Jones; Felipe García; César Cáceres; Patricia Sánchez-González; Edward Wallitt; Enrique J Gómez
Journal:  Int J Environ Res Public Health       Date:  2021-03-18       Impact factor: 3.390

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.